KKR considers selling stake in India’s $3 billion JB Pharma

KKR & Co. is reportedly considering selling its 53.8% controlling stake in Indian pharmaceutical company JB Chemicals & Pharmaceuticals Ltd. The US private equity firm is said to be exploring options and seeking financial advisers for a potential sale, with other buyout firms and industry players expressing preliminary interest. JB Pharma's shares have seen a 68% increase in the past year, valuing the company at just over $3 billion.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news